circRNA basic information
circBase ID: hsa_circ_0000055
Name: hsa_circ_CSF3R
Synonym: CSF3R-AS
Host Gene: CSF3R
Genomic location(hg19): chr1:36939396-36941065:+
Genomic location(hg38): chr1:36473795-36475464:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tumors; paired adjacent noncancerous tissues

Cell lines:

Huh6; HCCLM3; PLC/PRF/5; Huh7; Hep3B; LO2; HepG2; MHCC97H; HCCLM3-SR; HepG2-SR

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: CSF3R, RBMS3, STAT3, JAK2
Associated microRNA: -
Biological function: promotes proliferation, angiogenesis, invasion/metastasis and sorafenib resistance; inhibits apoptosis
Molecular mechanism: antisense circRNA binds parental CSF3R mRNA via 180-bp reverse complementary pairing, recruits RBMS3 to stabilize CSF3R mRNA, activates JAK2/STAT3; STAT3 acts as transcription factor of CSF3R-AS forming positive feedback loop
Biological pathway or process:

JAK/STAT (promotes); proliferation (promotes); angiogenesis (promotes); metastasis (promotes); invasion (promotes); apoptosis (inhibits); drug resistance (promotes)

Detected method:
Q
S
Validation methods:

RNA-seq; RT-qPCR; divergent primers PCR; RNase R Treatment; Sanger Sequencing; FISH / smFISH; Luciferase Reporter Assay; ChIP / ChIP-seq; RNA Pull-Down; Transfection; CCK8; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Tube Formation Assay; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; H&E Staining; Survival Analysis; Bioinformatics Analysis; Actinomycin D / DRB Stability Assay; Clinical Sample Validation

Clinical significance:

upregulated in HCC and correlated with poor prognosis; higher expression associated with worse OS and adverse clinicopathological features

Description:

CSF3R-AS (hsa_circ_0000055) is up-regulated in HCC and predicts worse overall survival. It promotes HCC proliferation, invasion/metastasis and angiogenesis while inhibiting apoptosis, and contributes to sorafenib resistance. Mechanistically, CSF3R-AS binds CSF3R mRNA and recruits RBMS3 to stabilize CSF3R, activating JAK2/STAT3; STAT3 in turn transcriptionally upregulates CSF3R-AS, forming a positive feedback loop.

Confidence score:

0.8913

Other information
Title:

CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R/JAK2/STAT3 positive feedback loop.

Journal: Cell death & disease
Published: 2025
PubMed ID: 40155591
Study type:

combined biological and clinical study

Data availability: All data are available upon request.
Code availability: -